Kanghua Biological (300841.SZ) released its performance for the first half of the year, with a net profit attributable to the mother company of 115 million yuan, a year-on-year decrease of 62.64%.

Cnstock app news, Kanghua Biotech (300841.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating income of 484 million yuan, a year-on-year decrease of 34.70%. The net profit attributable to shareholders of the listed company was 115 million yuan, a year-on-year decrease of 62.64%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 112 million yuan, a year-on-year decrease of 63.88%. The basic earnings per share was 0.8813 yuan.